Cart
sales@molnova.com
Norverapamil hydrochloride
CAS No. 67812-42-4
Norverapamil hydrochloride( ±)-Norverapamil hydrochloride | D591 hydrochloride )
Catalog No. M15590 CAS No. 67812-42-4
A calcium channel blocker and the main active metabolite of verapamil.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 315 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 621 | In Stock |
|
| 200MG | 870 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNorverapamil hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA calcium channel blocker and the main active metabolite of verapamil.
-
DescriptionA calcium channel blocker and the main active metabolite of verapamil.
-
In VitroNorverapamil hydrochloride ((±)-Norverapamil hydrochloride) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M. tuberculosis in the absence of other drugs. norverapamil, also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil. Verapamil and its major metabolite norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic.
-
In VivoNorverapamil hydrochloride (9 mg/kg; p.o.), a major metabolite of verapamil, has terminal half-life, AUC and Cmax values of 9.4 hours, 260 ng?h/ml, and 41.6 ng/mL, respectively. Animal Model:Male Sprague-Dawley rats Dosage:9 mg/kg (Pharmacokinetic Study)Administration:Oral administration Result:t1/2=9.4 hours;AUC=260 ng?h/mL;Cmax=41.6 ng/mL.
-
Synonyms±)-Norverapamil hydrochloride | D591 hydrochloride
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number67812-42-4
-
Formula Weight477.036
-
Molecular FormulaC26H37ClN2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 31 mg/mL
-
SMILESN#CC(C(C)C)(C1=CC=C(OC)C(OC)=C1)CCCNCCC2=CC=C(OC)C(OC)=C2.[H]Cl
-
Chemical NameBenzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee YS, et al. Xenobiotica. 2012 Aug;42(8):766-74.
2. Adams KN, et al. J Infect Dis. 2014 Aug 1;210(3):456-66.
3. Sawicki W. Eur J Pharm Biopharm. 2002 Jan;53(1):29-35.
molnova catalog
related products
-
DS16570511
DS16570511 is a cellular osmotic inhibitor of mitochondrial calcium monoab, which blocks MCU or MICU1-dependent Ca2+ influx.DS16570511 dose - dependent inhibition of serum-induced mitochondrial Ca2+ influx in HEK293A cells with IC50 of 7 M.DS16570511 inhibits the uptake of isolated Ca2+. mitochondria from human cells, rat heart and pig heart.
-
Barnidipine
Barnidipine is a dihydropyridine calcium channel blocker that has an IC50 value of 0.35 nM in potassium-induced tonic contraction of pig coronary artery.
-
N6-(2-Hydroxyethyl)a...
N6-(2-Hydroxyethyl)adenosine, a Ca2+ antagonist and anti-inflammatory agent, is associated with the regulation of cerebral and coronary circulation and is believed to exhibit sedative activity.
